643 results on '"Weiss, Heidi L"'
Search Results
102. Abstract P2-05-08: Integrin alpha6beta4 signaling switches double strand break repair from homologous recombination to non-homologous end joining to alter TNBC cells response to cisplatin
103. Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes
104. Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers
105. Using elderly educators to increase colorectal cancer screening
106. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy
107. The VR-DCEP regimen rescues mobilization failures and controls refractory disease in multiple myeloma
108. Integrin α6β4 signaling switches DNA repair from homologous recombination to non-homologous end-joining pathway to sensitize breast cancer cells to cisplatin
109. Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells
110. Abstract 1119: S100A4 alters mitochondrial metabolism to promote invasion and metastasis of non-small cell lung cancer cells through upregulation of NDUFS2
111. Abstract 3868: FND 4b decreases proliferation and increases apoptosis of triple negative breast cancer through AMPK activation
112. 85 – Sirt2 Regulates Intestinal Cell Proliferation and Differentiation
113. Su1015 – Wnt Signaling Regulates Sirt2 Expression in Intestinal Cells
114. 445 – Nt-Ntr1 Signaling Positively Regulates Intestinal Fatty Acid Uptake and Lipogenesis
115. Sa1104 – Deficiency of Nt-Ntr1 Signaling Prevents the Disruption of Bile Acid Homeostasis in Mice Fed High-Fat Diet
116. Tu1153 – Regulation of Ketogenesis by Wnt/β-Catenin/Pparγ Signaling in Human Colorectal Cancer Cells
117. S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2
118. 523 – Ksr1 and Exo70 Interact with Erk1/2 to Promote Neurotensin Secretion in Human Endocrine Cells
119. Kinase suppressor of Ras 1 and Exo70 promote fatty acid-stimulated neurotensin secretion through ERK1/2 signaling
120. Pharmacogenomic potential in advanced cancer patients
121. Induction of AMPK activation by N,N’-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers
122. Reduced-Dose Melphalan (140 or 100 mg/m2) Maintains Efficacy and Tolerability for Multiple Myeloma Patients with Advanced Age or Renal Impairment Undergoing Auto-HCT
123. Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky
124. De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer
125. Induction of AMPK activation by N,N’-Diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers
126. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor
127. Clinical Applications for Change-Point Analysis of Herpes Zoster Pain
128. Transforming growth factor-α: a surrogate endpoint biomarker?
129. Brain Edema in Meningiomas Is Associated with Increased Vascular Endothelial Growth Factor Expression
130. Serum retinol and HIV-1 RNA viral load in rapid and slow progressors
131. Bayesian monitoring of a phase 2 chemoprevention trial in high-risk cohorts for prostate cancer
132. FATTY ACID SYNTHASE: AN EARLY MOLECULAR MARKER OF PROGRESSION OF PROSTATIC ADENOCARCINOMA TO ANDROGEN INDEPENDENCE
133. Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theory
134. Neutralization and Enhancement of HIV-1 Infection by Sera from HIV-1 Infected Individuals Who Progress to Disease at Different Rates
135. Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance
136. Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors
137. Erbin Suppresses KSR1-Mediated RAS/RAF Signaling and Tumorigenesis in Colorectal Cancer
138. Abstract 1437: De novo fatty acid synthesis-driven sphingolipid metabolism promotes metastatic potential of colorectal cancer
139. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth
140. FFAR4 Is Involved in Regulation of Neurotensin Release From Neuroendocrine Cells and Male C57BL/6 Mice
141. Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer
142. Sa1627 - Sirt2 Protein Contributes to Intestinal Cell Differentiation
143. Su1206 - KSR1 Positively Regulates Erk1/2 Signaling and Neurotensin Secretion in Endocrine Cells
144. Mo1993 - Deptor, a Novel Target of Wnt/β-Catenin/C-Myc, is Overexpressed in Colorectal Cancer Cells and Contributes to their Growth
145. Sa1620 - Mitochondrial 3-Hydroxy-3-Methylglutaryl-Coa Synthase 2 (Hmgcs2) is a Target of Wnt/β-Catenin Signaling in Human Colorectal Cancer Cells
146. Mo1992 - HDAC6 is a Novel Regulator of Mtor Activity in Colorectal Cancer Cells
147. Su1205 - FFAR4 Agonists Stimulate Neurotensin Secretion In Vitro and In Vivo
148. Colorectal cancer lung metastasis treatment with polymer–drug nanoparticles
149. Extracellular redox state shift: A novel approach to target prostate cancer invasion
150. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.